Does NIVOLUMAB Cause Pulmonary infarction? 11 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Pulmonary infarction have been filed in association with NIVOLUMAB (OPDIVO). This represents 0.0% of all adverse event reports for NIVOLUMAB.
11
Reports of Pulmonary infarction with NIVOLUMAB
0.0%
of all NIVOLUMAB reports
4
Deaths
5
Hospitalizations
How Dangerous Is Pulmonary infarction From NIVOLUMAB?
Of the 11 reports, 4 (36.4%) resulted in death, 5 (45.5%) required hospitalization.
Is Pulmonary infarction Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NIVOLUMAB. However, 11 reports have been filed with the FAERS database.
What Other Side Effects Does NIVOLUMAB Cause?
Death (11,216)
Malignant neoplasm progression (9,363)
Off label use (5,208)
Diarrhoea (4,692)
Fatigue (3,709)
Pyrexia (3,454)
Intentional product use issue (3,297)
Rash (2,816)
Nausea (2,805)
Decreased appetite (2,619)
What Other Drugs Cause Pulmonary infarction?
ETHINYL ESTRADIOL\ETONOGESTREL (187)
DROSPIRENONE\ETHINYL ESTRADIOL (69)
TESTOSTERONE (45)
CYCLOPHOSPHAMIDE (32)
ADALIMUMAB (29)
METHOTREXATE (28)
RIVAROXABAN (28)
DEXAMETHASONE (27)
QUETIAPINE (26)
DOXORUBICIN (25)
Which NIVOLUMAB Alternatives Have Lower Pulmonary infarction Risk?
NIVOLUMAB vs NIVOLUMAB\RELATLIMAB-RMBW
NIVOLUMAB vs NIZATIDINE
NIVOLUMAB vs NOMEGESTROL
NIVOLUMAB vs NORDAZEPAM
NIVOLUMAB vs NOREPINEPHRINE